1. Butyrate induces ROS-mediated apoptosis by modulating miR-22/SIRT-1 pathway in hepatic cancer cells
   Kishor Pant et al, 2017, Redox Biology CrossRef
2. Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy
   Derek B. Oien et al, 2018, Front. Pharmacol. CrossRef
3. Mitochondrial Toxicity Induced by Chemotherapeutic Drugs
   Luciana L. Ferreira et al, 2018 CrossRef
4. Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies.
   Pierpaola Davalli et al, 2018, Oxid Med Cell Longev CrossRef
5. Genetic regulation of longevity and age-associated diseases through the methionine sulfoxide reductase system
   Derek B. Oien et al, 2018, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
6. Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma
   Tania Villanova et al, 2019, Proc Natl Acad Sci USA CrossRef
7. Combining hydrophilic chemotherapy and hydrophobic phytotherapy via tumor-targeted albumin–QDs nano-hybrids: covalent coupling and phospholipid complexation approaches
   Dina G. Zayed et al, 2019, J Nanobiotechnol CrossRef
8. Endogenous nucleotide as drug carrier: base-paired guanosine-5′-monophosphate:pemetrexed vesicles with enhanced anticancer capability
   Lei Xu et al, 2019, Sci. China Chem. CrossRef
9. Metabolic rewiring and redox alterations in malignant pleural mesothelioma
   Loredana Urso et al, 2019, Br J Cancer CrossRef
10. Cytotoxicity study and influence of SBA-15 surface polarity and pH on adsorption and release properties of anticancer agent pemetrexed
    Miroslav Almáši et al, 2019, Materials Science and Engineering: C CrossRef
11. Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function
    Lucie Hebert et al, 2017, Oncotarget CrossRef
12. MDM2-dependent Sirt1 degradation is a prerequisite for Sirt6-mediated cell death in head and neck cancers
    Jung Je Park et al, 2021, Exp Mol Med CrossRef
13. MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells
    Emeric Limagne et al, 2022, Cancer Cell CrossRef
14. New vistas in malignant mesothelioma: MicroRNA architecture and NRF2/MAPK signal transduction
    Manav Gandhi et al, 2020, Life Sciences CrossRef
15. Green Self-assembled Lactoferrin Carboxymethyl Cellulose Nanogels for Synergistic Chemo/herbal Breast Cancer Therapy
    Mai A. Atallah et al, 2022, Colloids and Surfaces B: Biointerfaces CrossRef
16. Study on combination therapy for lung cancer through pemetrexed‐loaded mesoporous polydopamine nanoparticles
    Jian Xu et al, 2022, J Biomedical Materials Res CrossRef
17. Low-dose metronomic chemotherapy triggers oxidized mtDNA sensing inside tumor cells to potentiate CD8+T anti-tumor immunity
    Wen Qiao et al, 2023, Cancer Letters CrossRef
18. SIRT1: an Intermediator of Key Pathways Regulating Pulmonary Diseases
    Yi-Zhu Jiang et al, 2024, Laboratory Investigation CrossRef
19. Lentinan mitigates pemetrexed chemoresistance by the PI3K/Akt pathway in non-small cell lung cancer
    Ping Tian et al, 2024, Cell Biochem Biophys CrossRef
20. The Growth of A549 Cell Line is Inhibited by Pemetrexed Through Up-regulation of hsa-MiR-320a Expression
    Akbar Ghorbani Alvanegh et al, 2024 CrossRef
21. Emerging role of sirtuins in non‑small cell lung cancer (Review)
    Min Zhou et al, 2024, Oncol Rep CrossRef
22. Repurposing of sericin combined with dactolisib or vitamin D to combat non-small lung cancer cells through computational and biological investigations
    Maged W. Helmy et al, 2024, Sci Rep CrossRef